nach oben

Erschienen in:

17.11.2020 | Original Article

The patient acceptable symptom state in oral lichen planus: identification of cut-off threshold scores in measures of pain and quality of life

verfasst von: Paswach Wiriyakijja, Stephen Porter, Stefano Fedele, Tim Hodgson, Roddy McMillan, Martina Shephard, Richeal Ni Riordain

Erschienen in: Clinical Oral Investigations | Ausgabe 6/2021

Einloggen, um Zugang zu erhalten

Abstract

Objectives

To establish thresholds of pain and quality of life scores corresponding to patient acceptable symptom state (PASS) in patients with oral lichen planus (OLP) and to assess demographic and clinical factors associated with achieving the PASS.

Methods

Prospective data from baseline and 4-month follow-up including Visual Analogue Scale (VAS), Numerical Rating Scale (NRS), 14-item Oral Health Impact Profile (OHIP-14) and 15-item and 26-item Chronic Oral Mucosal Disease Questionnaire (COMDQ-15; COMDQ-26) were collected from 281 patients with OLP. An anchoring approach based upon the patient’s opinion on acceptability of OLP status was applied. Associated factors for achieving the PASS were analysed using multivariate logistic regression.

Results

About two-thirds (68.7%) of participants rated their OLP status as acceptable. Cut-off thresholds for PASS were as follows: ≤ 28 mm for VAS, ≤ 3 for NRS, ≤ 18 for total OHIP-14, ≤ 26 for total COMDQ-15 and ≤ 48 for total COMDQ-26. Based upon results of multivariate logistic analysis, factors associated with being in PASS were lower pain intensity, lower depressive symptoms and lower disease activity of OLP.

Conclusion

The present study established PASS cut-off thresholds as a tool facilitating interpretation of pain and quality of life outcomes relevant to individuals with OLP.

Clinical relevance

Identified PASS estimates could be utilised as clinically important endpoints in clinical practice of OLP as well as eligibility criteria for recruiting participants in clinical trials assessing effectiveness of symptomatic intervention of OLP.

Nur mit Berechtigung zugänglich

Alrashdan MS, Cirillo N, McCullough M (2016) Oral lichen planus: a literature review and update. Arch Dermatol Res 308(8):539–551. https://doi.org/10.1007/s00403-016-1667-2CrossRefPubMed

Ni Riordain R, Meaney S, McCreary C (2011) Impact of chronic oral mucosal disease on daily life: preliminary observations from a qualitative study. Oral Dis 17(3):265–269. https://doi.org/10.1111/j.1601-0825.2010.01734.xCrossRefPubMed

Lodi G, Manfredi M, Mercadante V, Murphy R, Carrozzo M (2020) Interventions for treating oral lichen planus: corticosteroid therapies. Cochrane Database Syst Rev 2:Cd001168. https://doi.org/10.1002/14651858.CD001168.pub3CrossRefPubMed

Coon CD, Cappelleri JC (2016) Interpreting change in scores on patient-reported outcome instruments. Ther Innov Regul Sci 50(1):22–29. https://doi.org/10.1177/2168479015622667CrossRefPubMed

Pham T, Tubach F (2009) Patient acceptable symptomatic state (PASS). Joint Bone Spine 76(4):321–323. https://doi.org/10.1016/j.jbspin.2009.03.008CrossRefPubMed

Wiriyakijja P, Porter S, Fedele S, Hodgson T, McMillan R, Shephard M, Ni Riordain R (2020) Meaningful improvement thresholds in measures of pain and quality of life in oral lichen planus. Oral Dis. 26:1464–1473. https://doi.org/10.1111/odi.13379CrossRefPubMed

Tubach F, Ravaud P, Beaton D, Boers M, Bombardier C, Felson DT, van der Heijde D, Wells G, Dougados M (2007) Minimal clinically important improvement and patient acceptable symptom state for subjective outcome measures in rheumatic disorders. J Rheumatol 34(5):1188–1193PubMedPubMedCentral

Christie A, Dagfinrud H, Garratt AM, Ringen Osnes H, Hagen KB (2011) Identification of shoulder-specific patient acceptable symptom state in patients with rheumatic diseases undergoing shoulder surgery. J Hand Ther 24(1):53–60; quiz 61. https://doi.org/10.1016/j.jht.2010.10.006CrossRefPubMed

Seror R, Bootsma H, Saraux A, Bowman SJ, Theander E, Brun JG, Baron G, Le Guern V, Devauchelle-Pensec V, Ramos-Casals M, Valim V, Dorner T, Tzioufas A, Gottenberg JE, Solans Laque R, Mandl T, Hachulla E, Sivils KL, Ng WF, Fauchais AL, Bombardieri S, Priori R, Bartoloni E, Goeb V, Praprotnik S, Sumida T, Nishiyama S, Caporali R, Kruize AA, Vollenweider C, Ravaud P, Meiners P, Brito-Zeron P, Vitali C, Mariette X (2016) Defining disease activity states and clinically meaningful improvement in primary Sjogren’s syndrome with EULAR primary Sjogren’s syndrome disease activity (ESSDAI) and patient-reported indexes (ESSPRI). Ann Rheum Dis 75(2):382–389. https://doi.org/10.1136/annrheumdis-2014-206008CrossRefPubMed

10.

Emerson Kavchak AJ, Cook C, Hegedus EJ, Wright AA (2013) Identification of cut-points in commonly used hip osteoarthritis-related outcome measures that define the patient acceptable symptom state (PASS). Rheumatol Int 33(11):2773–2782. https://doi.org/10.1007/s00296-013-2813-1CrossRefPubMed

11.

Tubach F, Dougados M, Falissard B, Baron G, Logeart I, Ravaud P (2006) Feeling good rather than feeling better matters more to patients. Arthritis Rheum 55(4):526–530. https://doi.org/10.1002/art.22110CrossRefPubMed

12.

Wiriyakijja P, Porter S, Fedele S, Hodgson T, McMillan R, Shephard M, Ni Riordain R (2020) Development and validation of a short version of Chronic Oral Mucosal Disease Questionnaire (COMDQ-15). J Oral Pathol Med 49(1):55–62. https://doi.org/10.1111/jop.12964CrossRefPubMed

13.

Escudier M, Ahmed N, Shirlaw P, Setterfield J, Tappuni A, Black MM, Challacombe SJ (2007) A scoring system for mucosal disease severity with special reference to oral lichen planus. Br J Dermatol 157(4):765–770. https://doi.org/10.1111/j.1365-2133.2007.08106.xCrossRefPubMed

14.

Department of Health (2016) Alcohol guidelines review—report from the guidelines development group to the UK chief medical officers.

15.

Chainani-Wu N, Silverman S Jr, Reingold A, Bostrom A, Lozada-Nur F, Weintraub J (2008) Validation of instruments to measure the symptoms and signs of oral lichen planus. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 105(1):51–58. https://doi.org/10.1016/j.tripleo.2007.06.022CrossRefPubMed

16.

Slade GD (1997) Derivation and validation of a short-form oral health impact profile. Community Dent Oral Epidemiol 25(4):284–290. https://doi.org/10.1111/j.1600-0528.1997.tb00941.xCrossRefPubMed

17.

Ni Riordain R, McCreary C (2011) Validity and reliability of a newly developed quality of life questionnaire for patients with chronic oral mucosal diseases. J Oral Pathol Med 40(8):604–609. https://doi.org/10.1111/j.1600-0714.2011.01021.xCrossRefPubMed

18.

Ni Riordain R, Hodgson T, Porter S, Fedele S (2016) Validity and reliability of the Chronic Oral Mucosal Diseases Questionnaire in a UK population. J Oral Pathol Med 45(8):613–616. https://doi.org/10.1111/jop.12425CrossRefPubMed

19.

Bjelland I, Dahl AA, Haug TT, Neckelmann D (2002) The validity of the Hospital Anxiety and Depression Scale. An updated literature review. J Psychosom Res 52(2):69–77. https://doi.org/10.1016/s0022-3999(01)00296-3CrossRefPubMed

20.

Schellekens MPJ, van den Hurk DGM, Prins JB, Molema J, van der Drift MA, Speckens AEM (2016) The suitability of the Hospital Anxiety and Depression Scale, Distress Thermometer and other instruments to screen for psychiatric disorders in both lung cancer patients and their partners. Journal of affective disorders 203:176–183. https://doi.org/10.1016/j.jad.2016.05.044CrossRefPubMed

21.

Alharbi H, Alshehry A (2019) Perceived stress and coping strategies among ICU nurses in government tertiary hospitals in Saudi Arabia: a cross-sectional study. Ann Saudi Med 39(1):48–55. https://doi.org/10.5144/0256-4947.2019.48CrossRefPubMedPubMedCentral

22.

Wiriyakijja P, Porter S, Fedele S, Hodgson T, McMillan R, Shephard M, Ni Riordain R (2020) Validation of the HADS and PSS-10 and psychological status in patients with oral lichen planus. Oral Dis 26(1):96–110. https://doi.org/10.1111/odi.13220CrossRefPubMed

23.

Terwee CB, Bot SD, de Boer MR, van der Windt DA, Knol DL, Dekker J, Bouter LM, de Vet HC (2007) Quality criteria were proposed for measurement properties of health status questionnaires. J Clin Epidemiol 60(1):34–42. https://doi.org/10.1016/j.jclinepi.2006.03.012CrossRefPubMed

24.

King MT (2011) A point of minimal important difference (MID): a critique of terminology and methods. Expert Rev Pharmacoecon Outcomes Res 11(2):171–184. https://doi.org/10.1586/erp.11.9CrossRefPubMed

25.

Gonzalez-Moles MA, Ruiz-Avila I, Gonzalez-Ruiz L, Ayen A, Gil-Montoya JA, Ramos-Garcia P (2019) Malignant transformation risk of oral lichen planus: a systematic review and comprehensive meta-analysis. Oral Oncol 96:121–130. https://doi.org/10.1016/j.oraloncology.2019.07.012CrossRefPubMed

Titel: The patient acceptable symptom state in oral lichen planus: identification of cut-off threshold scores in measures of pain and quality of life
verfasst von: Paswach Wiriyakijja
Stephen Porter
Stefano Fedele
Tim Hodgson
Roddy McMillan
Martina Shephard
Richeal Ni Riordain
Publikationsdatum: 17.11.2020
Verlag: Springer Berlin Heidelberg
Erschienen in: Clinical Oral Investigations / Ausgabe 6/2021
Print ISSN: 1432-6981
Elektronische ISSN: 1436-3771
DOI: https://doi.org/10.1007/s00784-020-03695-6

Bestellen Sie unseren kostenlosen Newsletter Update Zahnmedizin und bleiben Sie gut informiert – ganz bequem per eMail.

Newsletter bestellen

Springer Medizin

The patient acceptable symptom state in oral lichen planus: identification of cut-off threshold scores in measures of pain and quality of life